enGene Therapeutics ENGN Balance Sheet (2022-2026)

NASDAQ ENGN
$1.77 -0.08 (-4.32%)
At close: Aug 20, 2026 · 4:00 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Oct2022 Jan2023 Apr2023 Jul2023 Oct2023 Jan2024 Apr2024 Jul2024 Oct2024 Jan2025 Apr2025 Jul2025 Oct2025 Jan2026 Apr2026
Accumulated Depreciation (Quarter) 1.55M1.73M1.81M1.89M1.53M1.61M1.71M1.82M1.93M2.10M2.29M2.46M
Assets
Current Assets
Cash & Equivalents (Quarter) 20.43M81.52M85.65M264.81M257.68M173.00M62.35M57.55M32.62M50.15M36.61M29.83M
Prepaid Assets (Quarter) 0.74M1.50M2.72M3.51M4.70M8.63M8.00M9.98M8.62M6.65M12.00M10.64M
Current Assets (Quarter) 22.58M85.44M89.58M269.61M262.69M247.36M222.32M227.97M211.31M201.39M289.22M270.00M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.39M0.59M0.99M1.11M1.01M1.17M2.70M1.55M1.88M2.48M2.44M2.33M
Long-Term Investments (Quarter) 59.53M58.98M34.11M23.01M8.52M36.60M26.71M
Other Non-Current Assets (Quarter) 0.94M0.93M0.97M0.97M1.38M1.37M1.58M1.38M1.38M1.36M1.39M1.38M
Non-Current Assets (Quarter) 1.33M1.52M3.84M3.92M4.18M63.81M63.61M38.68M34.24M20.08M47.90M37.52M
Assets (Quarter) 23.91M86.96M93.42M273.53M266.88M311.17M285.93M266.65M245.55M221.47M337.11M307.52M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.72M1.16M1.27M0.21M2.86M1.41M2.60M1.57M2.38M6.69M2.44M1.79M
Notes Payables (Quarter) 1.26M39.98M0.56M1.34M0.70M1.69M3.57M5.41M8.00M0.19M0.19M
Payables (Quarter) 1.99M39.98M1.72M1.27M0.21M4.20M2.11M4.29M5.14M7.80M14.69M2.62M1.99M
Accumulated Expenses (Quarter) 0.68M0.81M1.55M5.67M8.83M3.48M8.24M12.43M2.91M15.28M19.67M2.15M
Other Accumulated Expenses (Quarter) 0.11M0.06M0.27M0.40M0.23M0.56M0.51M0.61M0.58M0.23M0.95M
Current Leases (Quarter) 0.39M0.42M0.42M0.42M0.42M0.43M1.53M2.01M2.32M2.29M
Current Taxes (Quarter) 0.02M0.04M0.01M0.03M0.09M0.33M0.57M0.02M
Total Current Liabilities (Quarter) 5.10M5.26M6.91M6.30M13.46M14.66M12.96M18.00M20.44M31.98M24.61M21.48M
Non-Current Liabilities
Non-Current Debt (Quarter) 9.65M9.22M22.53M22.73M21.61M22.47M21.70M20.02M17.71M15.32M24.74M24.91M
Convertible Debt (Quarter) 17.41M
Preferred Stock Liabilities (Quarter) 49.66M1.55M1.55M
Operating Leases (Quarter) 1.60M1.53M1.48M1.43M1.33M1.34M6.73M6.46M6.22M5.96M
Other Non-Current Liabilities (Quarter) 11.46M
Total Non-Current Liabilities (Quarter) 35.95M14.47M31.04M30.56M36.55M
Total Liabilities (Quarter) 47.41M14.47M31.04M30.56M36.55M38.56M35.98M39.36M44.88M53.76M55.57M52.36M
Shareholder's Equity
Total Debt (Quarter) 9.65M9.22M22.53M22.73M21.61M22.47M21.70M20.02M17.71M15.32M24.74M24.91M
Common Equity (Quarter) -76.61M-84.01M-89.24M-93.92M72.49M62.38M242.97M230.33M272.61M249.95M227.29M200.67M167.71M281.55M255.17M
Liabilities and Shareholders Equity (Quarter) 23.91M86.96M93.42M273.53M266.88M311.17M285.93M266.65M245.55M221.47M337.11M307.52M
Retained Earnings (Quarter) -1.02M-199.59M-210.30M-1.02M-239.43M-1.42M-1.27M-0.97M-334.15M-372.03M-401.80M-432.00M
Treasury Shares (Quarter) 5.56M5.56M5.56M0.27M0.27M0.27M